Works by Cao, Han-Yu

Results: 12

Venetoclax with hypomethylating agents versus intensive chemotherapy in newly diagnosed acute myeloid leukemia with myelodysplasia related changes: A propensity score-matched analysis based on International Consensus Classification.

Published in:

2024

By:

Wan, Chao-Ling;
Liu, Yu-Qing;
Liu, Fang-Tong;
Huang, Yuan-Hong;
Cao, Han-Yu;
Huang, Si-Man;
Tan, Kai-Wen;
Ge, Shuai-Shuai;
Wang, Miao;
Liu, Mei-Jing;
Wang, Zi-Hao;
Li, Zheng;
Xue, Sheng-Li;
Dai, Hai-Ping

Publication type:

Letter

Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00948-x

By:

Wang, Miao;
Cao, Han-Yu;
Tan, Kai-Wen;
Qiu, Qiao-Cheng;
Huang, Yuan-Hong;
Ge, Shuai-shuai;
Wang, Zi-Hao;
Chen, Jia;
Tang, Xiao-Wen;
Wu, De-Pei;
Xue, Sheng-Li;
Li, Zheng;
Dai, Hai-Ping

Publication type:

Article

Patients with CML in the lymphoid blastic phase have inferior response to anti‐CD19 CAR T‐cell therapy compared to de novo Ph‐positive B cell acute lymphoblastic leukemia.

Published in:

HemaSphere, 2024, v. 8, n. 2, p. 1, doi. 10.1002/hem3.49

By:

Liu, Mei‐Jing;
Tan, Kai‐Wen;
Cao, Han‐Yu;
Huang, Si‐Man;
Qian, Chong‐Sheng;
Xue, Sheng‐Li;
Dai, Hai‐Ping;
Gong, Wen‐Jie

Publication type:

Article

Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy.

Published in:

Hematological Oncology, 2023, v. 41, n. 3, p. 301, doi. 10.1002/hon.3088

By:

Cao, Han‐Yu;
Li, Ling;
Xue, Sheng‐Li;
Dai, Hai‐Ping

Publication type:

Article

Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantation.

Published in:

Annals of Hematology, 2024, v. 103, n. 12, p. 6003, doi. 10.1007/s00277-024-06137-5

By:

Liu, Fang-Tong;
Wan, Chao-Ling;
Huang, Yuan-Hong;
Cao, Han-Yu;
Lyu, Xiao-Yu;
Wang, Zi-Hao;
Huang, Si-Man;
Tan, Kai-Wen;
Ge, Shuai-Shuai;
Zhang, Yang;
Xue, Sheng-Li

Publication type:

Article

Genetic and clinical characteristics of acute B-cell lymphoblastic leukemia with MEF2D fusions and report of two novel MEF2D rearrangements.

Published in:

Annals of Hematology, 2024, v. 103, n. 10, p. 4155, doi. 10.1007/s00277-024-05868-9

By:

Cao, Han-Yu;
Li, Hui-Ying;
Cai, Wen-Zhi;
Huang, Yuan-Hong;
Qiu, Qiao-Cheng;
Li, Zheng-;
Xu, Yang;
Xue, Sheng-Li;
Dai, Hai-Ping

Publication type:

Article

Rapid molecular response to dasatinib in Ph-like acute lymphoblastic leukemia patients with ABL1 rearrangements: case series and literature review.

Published in:

Annals of Hematology, 2023, v. 102, n. 9, p. 2397, doi. 10.1007/s00277-023-05236-z

By:

Tan, Kai-Wen;
Zhu, Yi-Yan;
Qiu, Qiao-Cheng;
Wang, Man;
Shen, Hong-Jie;
Huang, Si-Man;
Cao, Han-Yu;
Wan, Chao-Ling;
Li, Yan-Yan;
Dai, Hai-Ping;
Xue, Sheng-Li

Publication type:

Article

Comparing the efficacy of salvage regimens for relapsed/refractory B-cell acute lymphoblastic leukaemia: a systematic review and network meta-analysis.

Published in:

Annals of Hematology, 2023, v. 102, n. 1, p. 155, doi. 10.1007/s00277-022-05040-1

By:

Cao, Han-Yu;
Wan, Chao-Ling;
Xue, Sheng-Li

Publication type:

Article

Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine.

Published in:

OncoTargets & Therapy, 2022, v. 15, p. 159, doi. 10.2147/OTT.S336715

By:

Zhang, Lei-Si;
Wang, Jun;
Xu, Ming-Zhu;
Wu, Tian-Mei;
Huang, Si-Man;
Cao, Han-Yu;
Sun, Ai-Ning;
Liu, Song-Bai;
Xue, Sheng-Li

Publication type:

Article

Preemptive inotuzumab ozogamicin eradicated measurable residual disease in Ph‐negative acute lymphoblastic leukemia relapsed post CD19 CART therapy.

Published in:

2023

By:

Huang, Si‐Man;
Wan, Chao‐Ling;
Cao, Han‐Yu;
Li, Yan‐Yan;
Qian, Chong‐Sheng;
Zhou, Hai‐Xia;
Xu, Ming‐Zhu;
Hu, Xiao‐Hui;
Dai, Lan;
Dai, Hai‐Ping;
Xue, Sheng‐Li

Publication type:

Case Study

Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report.

Published in:

2023

By:

Huang, Si‐Man;
Tao, Tao;
Wan, Chao‐Ling;
Wu, Tian‐Mei;
Cao, Han‐Yu;
Qiu, Yan;
Shen, Xiang‐Dong;
Wang, Bin‐Ru;
Ge, Shuai‐Shuai;
Li, Yan‐Yan;
Zhang, Tong‐Tong;
Wu, Bing;
Xue, Sheng‐Li

Publication type:

Case Study

Efficiency of anti‐VEGF therapy in central nervous system AML relapse: A case report and literature review.

Published in:

Clinical Case Reports, 2022, v. 10, n. 2, p. 1, doi. 10.1002/ccr3.5367

By:

Cao, Han‐Yu;
Tao, Tao;
Shen, Xiang‐Dong;
Bai, Lian;
Wan, Chao‐Ling;
Wu, De‐Pei;
Li, Jin‐Li;
Xue, Sheng‐Li

Publication type:

Article